[Combination chemotherapy with nedaplatin and paclitaxel for ovarian cancer]

Nihon Rinsho. 2004 Oct:62 Suppl 10:550-3.

[Article in Japanese]

Authors

Toshiya Yamamoto¹, Ken-ichirou Morishige, Yukinobu Ohta, Shoji Kamiura, Fumitaka Saji

Affiliation

¹ Department of Gynecology, Osaka Medical Center for Cancer and Cardiovascular Diseases.

PMID: 15535306

No abstract available

Publication types

Clinical Trial
Clinical Trial, Phase I

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Gynecologic Surgical Procedures
Humans
Middle Aged
Organoplatinum Compounds / administration & dosage
Organoplatinum Compounds / adverse effects
Ovarian Neoplasms / drug therapy*
Paclitaxel / administration & dosage
Paclitaxel / adverse effects
Thrombocytopenia / chemically induced
Treatment Outcome

Substances

Organoplatinum Compounds
nedaplatin
Paclitaxel